Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.0 - $334.83 $0 - $60.2 Million
-179,661 Reduced 99.78%
398 $2,000
Q1 2024

May 15, 2024

SELL
$191.17 - $325.63 $13.2 Million - $22.5 Million
-69,156 Reduced 27.75%
180,059 $58.6 Million
Q4 2023

Feb 15, 2024

BUY
$160.99 - $215.69 $15.4 Million - $20.6 Million
95,574 Added 62.21%
249,215 $47.5 Million
Q3 2023

Nov 07, 2023

BUY
$194.33 - $283.97 $19.7 Million - $28.8 Million
101,557 Added 194.99%
153,641 $30.6 Million
Q2 2023

Aug 03, 2023

BUY
$223.05 - $302.68 $1.18 Million - $1.6 Million
5,301 Added 11.33%
52,084 $14.9 Million
Q1 2023

May 04, 2023

BUY
$175.41 - $217.92 $1.35 Million - $1.68 Million
7,690 Added 19.67%
46,783 $10.1 Million
Q4 2022

Feb 13, 2023

BUY
$204.38 - $296.82 $6.38 Million - $9.26 Million
31,192 Added 394.79%
39,093 $8.04 Million
Q3 2022

Nov 03, 2022

BUY
$195.21 - $310.53 $907,531 - $1.44 Million
4,649 Added 142.96%
7,901 $2.2 Million
Q2 2022

Aug 12, 2022

SELL
$115.91 - $214.48 $599,254 - $1.11 Million
-5,170 Reduced 61.39%
3,252 $621,000
Q1 2022

May 16, 2022

SELL
$127.96 - $207.36 $8.25 Million - $13.4 Million
-64,466 Reduced 88.45%
8,422 $1.75 Million
Q4 2021

Feb 14, 2022

BUY
$165.13 - $241.83 $4.37 Million - $6.39 Million
26,436 Added 56.91%
72,888 $13 Million
Q3 2021

Nov 09, 2021

SELL
$163.99 - $235.57 $31 Million - $44.5 Million
-188,969 Reduced 80.27%
46,452 $9.56 Million
Q2 2021

Aug 13, 2021

BUY
$131.45 - $201.49 $24.9 Million - $38.2 Million
189,790 Added 415.92%
235,421 $44.7 Million
Q1 2021

May 13, 2021

BUY
$92.73 - $142.05 $124,072 - $190,062
1,338 Added 3.02%
45,631 $5.94 Million
Q4 2020

Feb 11, 2021

BUY
$67.44 - $103.72 $1.71 Million - $2.62 Million
25,301 Added 133.22%
44,293 $4.6 Million
Q3 2020

Nov 12, 2020

SELL
$42.79 - $75.8 $382,457 - $677,500
-8,938 Reduced 32.0%
18,992 $1.44 Million
Q2 2020

Aug 12, 2020

BUY
$27.25 - $47.53 $277,568 - $484,140
10,186 Added 57.41%
27,930 $1.32 Million
Q1 2020

May 13, 2020

SELL
$23.16 - $47.74 $248,089 - $511,390
-10,712 Reduced 37.64%
17,744 $588,000
Q4 2019

Feb 10, 2020

BUY
$29.4 - $44.98 $713,920 - $1.09 Million
24,283 Added 581.91%
28,456 $1.25 Million
Q3 2019

Nov 14, 2019

SELL
$29.71 - $55.23 $7,843 - $14,580
-264 Reduced 5.95%
4,173 $125,000
Q2 2019

Aug 14, 2019

BUY
$29.73 - $66.02 $131,912 - $292,930
4,437 New
4,437 $253,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.